117 related articles for article (PubMed ID: 36939068)
1. HIV medical care interruption among people living with HIV in Spain, 2004-2020.
Izquierdo R; Rava M; Moreno-García E; Blanco JR; Asensi V; Cervero M; Curran A; Rubio R; Iribarren JA; Jarrín I;
AIDS; 2023 Jul; 37(8):1277-1284. PubMed ID: 36939068
[TBL] [Abstract][Full Text] [Related]
2. Incidence of and risk factors for medical care interruption in people living with HIV in recent years.
Fournier AL; Yazdanpanah Y; Verdon R; Lariven S; Mackoumbou-Nkouka C; Phung BC; Papot E; Parienti JJ; Landman R; Champenois K
PLoS One; 2019; 14(3):e0213526. PubMed ID: 30865722
[TBL] [Abstract][Full Text] [Related]
3. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients.
Portocarrero Nuñez JA; Gonzalez-Garcia J; Berenguer J; Gallego MJV; Loyarte JAI; Metola L; Bernal E; Navarro G; Del Amo J; Jarrín I;
Medicine (Baltimore); 2018 Sep; 97(38):e12238. PubMed ID: 30235668
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors for medical care interruption in people living with HIV in a French provincial city.
Fournier AL; Parienti JJ; Champenois K; Feret P; Papot E; Yazdanpanah Y; Verdon R
PLoS One; 2020; 15(10):e0240417. PubMed ID: 33057366
[TBL] [Abstract][Full Text] [Related]
5. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.
Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V;
J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417
[TBL] [Abstract][Full Text] [Related]
6. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
[TBL] [Abstract][Full Text] [Related]
7. Late presentation for HIV remains a major health issue in Spain: Results from a multicenter cohort study, 2004-2018.
Rava M; Domínguez-Domínguez L; Bisbal O; López-Cortés LF; Busca C; Antela A; González-Ruano P; Hernández C; Iribarren JA; Rubio R; Moreno S; Jarrín I;
PLoS One; 2021; 16(4):e0249864. PubMed ID: 33882093
[TBL] [Abstract][Full Text] [Related]
8. Trends in HIV testing, prevalence among first-time testers, and incidence in most-at-risk populations in Spain: the EPI-VIH Study, 2000 to 2009.
Diez M; Bleda MJ; Varela JR; Ordonana J; Azpiri MA; Vall M; Santos C; Viloria L; de Armas C; Urena JM; Trullen J; Pueyo I; Martinez B; Puerta T; Vera M; Sanz I; Junquera ML; Landa MC; Martinez E; Camara MM; Belda J; Bru FJ; Diaz A;
Euro Surveill; 2014 Nov; 19(47):20971. PubMed ID: 25443036
[TBL] [Abstract][Full Text] [Related]
9. Incidence rate, predictors and outcomes of interruption of HIV care: nationwide results from the Belgian HIV cohort.
Van Beckhoven D; Florence E; De Wit S; Wyndham-Thomas C; Sasse A; Van Oyen H; Macq J;
HIV Med; 2020 Oct; 21(9):557-566. PubMed ID: 32627351
[TBL] [Abstract][Full Text] [Related]
10. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
[TBL] [Abstract][Full Text] [Related]
11. Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?
Baldé A; Lièvre L; Maiga AI; Diallo F; Maiga IA; Costagliola D; Abgrall S
PLoS One; 2020; 15(9):e0238687. PubMed ID: 32911516
[TBL] [Abstract][Full Text] [Related]
12. No change in viral set point or CD4 cell decline among antiretroviral treatment-naïve, HIV-1-infected individuals enrolled in the Danish HIV Cohort Study in 1995-2010.
Helleberg M; Kronborg G; Larsen CS; Pedersen G; Pedersen C; Obel N; Gerstoft J
HIV Med; 2013 Jul; 14(6):362-9. PubMed ID: 23433434
[TBL] [Abstract][Full Text] [Related]
13. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.
; Lodwick RK; Sabin CA; Porter K; Ledergerber B; van Sighem A; Cozzi-Lepri A; Khaykin P; Mocroft A; Jacobson L; De Wit S; Obel N; Castagna A; Wasmuth JC; Gill J; Klein MB; Gange S; Riera M; Mussini C; Gutiérrez F; Touloumi G; Carrieri P; Guest JL; Brockmeyer NH; Phillips AN
Lancet; 2010 Jul; 376(9738):340-5. PubMed ID: 20638118
[TBL] [Abstract][Full Text] [Related]
14. Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa.
Bock P; Nel K; Fatti G; Sloot R; Ford N; Voget J; Gunst C; Grobbelaar N; Louis F; Floyd S; Hayes R; Ayles H; Beyers N; Fidler S;
HIV Med; 2019 Jul; 20(6):392-403. PubMed ID: 30963667
[TBL] [Abstract][Full Text] [Related]
15. Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: role of antiretroviral therapy.
Masiá M; Padilla S; Álvarez D; López JC; Santos I; Soriano V; Hernández-Quero J; Santos J; Tural C; del Amo J; Gutiérrez F;
AIDS; 2013 Jan; 27(2):181-9. PubMed ID: 23018442
[TBL] [Abstract][Full Text] [Related]
16. Incidence of hepatitis C virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: increasing rates of HCV diagnosis but not of HCV seroconversions.
Sobrino-Vegas P; Monge Corella S; Serrano-Villar S; Gutiérrez F; Blanco JR; Santos I; del Romero J; Segura F; Portilla J; Guillén SM; del Amo J;
PLoS One; 2014; 9(12):e116226. PubMed ID: 25549224
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
Kovari H; Ledergerber B; Battegay M; Rauch A; Hirschel B; Foguena AK; Vernazza P; Bernasconi E; Mueller NJ; Weber R
Clin Infect Dis; 2010 Feb; 50(4):502-11. PubMed ID: 20085465
[TBL] [Abstract][Full Text] [Related]
18. Declining risk of triple-class antiretroviral drug failure in Danish HIV-infected individuals.
Lohse N; Obel N; Kronborg G; Laursen A; Pedersen C; Larsen CS; Kvinesdal B; Sørensen HT; Gerstoft J
AIDS; 2005 May; 19(8):815-22. PubMed ID: 15867496
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis incidence and mortality in people living with human immunodeficiency virus: a Danish nationwide cohort study.
Martin-Iguacel R; Llibre JM; Pedersen C; Obel N; Stærke NB; Åhsberg J; Ørsted I; Holden I; Kronborg G; Mohey R; Rasmussen LD; Johansen IS
Clin Microbiol Infect; 2022 Apr; 28(4):570-579. PubMed ID: 34438070
[TBL] [Abstract][Full Text] [Related]
20. AIDS in the era of antiretroviral therapy: Changes in incidence rates and predictors of AIDS among people living with HIV under clinical care in Germany, a cohort study 1999-2018.
Pantke A; Kollan C; Gunsenheimer-Bartmeyer B; Jensen BO; Stephan C; Degen O; Schürmann D; Kurth T; Bremer V; Koppe U;
HIV Med; 2023 Jul; 24(7):794-806. PubMed ID: 36949726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
